Old Question Revisited: Are High-Protein Diets Safe in Pregnancy?

Background: A previous randomized dietary intervention in pregnant women from the 1970s, the Harlem Trial, reported retarded fetal growth and excesses of very early preterm births and neonatal deaths among those receiving high-protein supplementation. Due to ethical challenges, these findings have n...

Full description

Bibliographic Details
Main Authors: Thorhallur I. Halldorsson, Bryndis E. Birgisdottir, Anne L. Brantsæter, Helle Margrete Meltzer, Margaretha Haugen, Inga Thorsdottir, Anna S. Olafsdottir, Sjurdur F. Olsen
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/13/2/440
id doaj-1406aab7c1404649bfd5e218ba7054a6
record_format Article
spelling doaj-1406aab7c1404649bfd5e218ba7054a62021-01-30T00:02:42ZengMDPI AGNutrients2072-66432021-01-011344044010.3390/nu13020440Old Question Revisited: Are High-Protein Diets Safe in Pregnancy?Thorhallur I. Halldorsson0Bryndis E. Birgisdottir1Anne L. Brantsæter2Helle Margrete Meltzer3Margaretha Haugen4Inga Thorsdottir5Anna S. Olafsdottir6Sjurdur F. Olsen7Faculty of Food Science and Nutrition, School of Health Sciences, University of Iceland, 101 Reykjavik, IcelandFaculty of Food Science and Nutrition, School of Health Sciences, University of Iceland, 101 Reykjavik, IcelandDivision of Infection Control and Environmental Health, Norwegian Institute of Public Health, 0213 Oslo, NorwayDivision of Infection Control and Environmental Health, Norwegian Institute of Public Health, 0213 Oslo, NorwayDivision of Infection Control and Environmental Health, Norwegian Institute of Public Health, 0213 Oslo, NorwayFaculty of Food Science and Nutrition, School of Health Sciences, University of Iceland, 101 Reykjavik, IcelandFaculty of Health Promotion, Sport and Leisure Studies, School of Education, University of Iceland, 105 Reykjavik, IcelandCentre for Foetal Programming, Department of Epidemiology Research, Statens Serum Institut, 2300 Copenhagen, DenmarkBackground: A previous randomized dietary intervention in pregnant women from the 1970s, the Harlem Trial, reported retarded fetal growth and excesses of very early preterm births and neonatal deaths among those receiving high-protein supplementation. Due to ethical challenges, these findings have not been addressed in intervention settings. Exploring these findings in an observational setting requires large statistical power due to the low prevalence of these outcomes. The aim of this study was to investigate if the findings on high protein intake could be replicated in an observational setting by combining data from two large birth cohorts. Methods: Individual participant data on singleton pregnancies from the Danish National Birth Cohort (DNBC) (<i>n</i> = 60,141) and the Norwegian Mother, Father and Child Cohort Study (MoBa) (<i>n</i> = 66,302) were merged after a thorough harmonization process. Diet was recorded in mid-pregnancy and information on birth outcomes was extracted from national birth registries. Results: The prevalence of preterm delivery, low birth weight and fetal and neonatal deaths was 4.77%, 2.93%, 0.28% and 0.17%, respectively. Mean protein intake (standard deviation) was 89 g/day (23). Overall high protein intake (>100 g/day) was neither associated with low birth weight nor fetal or neonatal death. Mean birth weight was essentially unchanged at high protein intakes. A modest increased risk of preterm delivery [odds ratio (OR): 1.10 (95% confidence interval (CI): 1.01, 1.19)] was observed for high (>100 g/day) compared to moderate protein intake (80–90 g/day). This estimate was driven by late preterm deliveries (weeks 34 to <37) and greater risk was not observed at more extreme intakes. Very low (<60 g/day) compared to moderate protein intake was associated with higher risk of having low-birth weight infants [OR: 1.59 (95%CI: 1.25, 2.03)]. Conclusions: High protein intake was weakly associated with preterm delivery. Contrary to the results from the Harlem Trial, no indications of deleterious effects on fetal growth or perinatal mortality were observed.https://www.mdpi.com/2072-6643/13/2/440DNBCMoBadietproteinpregnancycomplications
collection DOAJ
language English
format Article
sources DOAJ
author Thorhallur I. Halldorsson
Bryndis E. Birgisdottir
Anne L. Brantsæter
Helle Margrete Meltzer
Margaretha Haugen
Inga Thorsdottir
Anna S. Olafsdottir
Sjurdur F. Olsen
spellingShingle Thorhallur I. Halldorsson
Bryndis E. Birgisdottir
Anne L. Brantsæter
Helle Margrete Meltzer
Margaretha Haugen
Inga Thorsdottir
Anna S. Olafsdottir
Sjurdur F. Olsen
Old Question Revisited: Are High-Protein Diets Safe in Pregnancy?
Nutrients
DNBC
MoBa
diet
protein
pregnancy
complications
author_facet Thorhallur I. Halldorsson
Bryndis E. Birgisdottir
Anne L. Brantsæter
Helle Margrete Meltzer
Margaretha Haugen
Inga Thorsdottir
Anna S. Olafsdottir
Sjurdur F. Olsen
author_sort Thorhallur I. Halldorsson
title Old Question Revisited: Are High-Protein Diets Safe in Pregnancy?
title_short Old Question Revisited: Are High-Protein Diets Safe in Pregnancy?
title_full Old Question Revisited: Are High-Protein Diets Safe in Pregnancy?
title_fullStr Old Question Revisited: Are High-Protein Diets Safe in Pregnancy?
title_full_unstemmed Old Question Revisited: Are High-Protein Diets Safe in Pregnancy?
title_sort old question revisited: are high-protein diets safe in pregnancy?
publisher MDPI AG
series Nutrients
issn 2072-6643
publishDate 2021-01-01
description Background: A previous randomized dietary intervention in pregnant women from the 1970s, the Harlem Trial, reported retarded fetal growth and excesses of very early preterm births and neonatal deaths among those receiving high-protein supplementation. Due to ethical challenges, these findings have not been addressed in intervention settings. Exploring these findings in an observational setting requires large statistical power due to the low prevalence of these outcomes. The aim of this study was to investigate if the findings on high protein intake could be replicated in an observational setting by combining data from two large birth cohorts. Methods: Individual participant data on singleton pregnancies from the Danish National Birth Cohort (DNBC) (<i>n</i> = 60,141) and the Norwegian Mother, Father and Child Cohort Study (MoBa) (<i>n</i> = 66,302) were merged after a thorough harmonization process. Diet was recorded in mid-pregnancy and information on birth outcomes was extracted from national birth registries. Results: The prevalence of preterm delivery, low birth weight and fetal and neonatal deaths was 4.77%, 2.93%, 0.28% and 0.17%, respectively. Mean protein intake (standard deviation) was 89 g/day (23). Overall high protein intake (>100 g/day) was neither associated with low birth weight nor fetal or neonatal death. Mean birth weight was essentially unchanged at high protein intakes. A modest increased risk of preterm delivery [odds ratio (OR): 1.10 (95% confidence interval (CI): 1.01, 1.19)] was observed for high (>100 g/day) compared to moderate protein intake (80–90 g/day). This estimate was driven by late preterm deliveries (weeks 34 to <37) and greater risk was not observed at more extreme intakes. Very low (<60 g/day) compared to moderate protein intake was associated with higher risk of having low-birth weight infants [OR: 1.59 (95%CI: 1.25, 2.03)]. Conclusions: High protein intake was weakly associated with preterm delivery. Contrary to the results from the Harlem Trial, no indications of deleterious effects on fetal growth or perinatal mortality were observed.
topic DNBC
MoBa
diet
protein
pregnancy
complications
url https://www.mdpi.com/2072-6643/13/2/440
work_keys_str_mv AT thorhallurihalldorsson oldquestionrevisitedarehighproteindietssafeinpregnancy
AT bryndisebirgisdottir oldquestionrevisitedarehighproteindietssafeinpregnancy
AT annelbrantsæter oldquestionrevisitedarehighproteindietssafeinpregnancy
AT hellemargretemeltzer oldquestionrevisitedarehighproteindietssafeinpregnancy
AT margarethahaugen oldquestionrevisitedarehighproteindietssafeinpregnancy
AT ingathorsdottir oldquestionrevisitedarehighproteindietssafeinpregnancy
AT annasolafsdottir oldquestionrevisitedarehighproteindietssafeinpregnancy
AT sjurdurfolsen oldquestionrevisitedarehighproteindietssafeinpregnancy
_version_ 1724318465916928000